Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-012943
Filing Date
2025-05-01
Accepted
2025-05-01 16:34:05
Documents
1
Period of Report
2025-04-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 9809
  Complete submission text file 0001127602-25-012943.txt   11347
Mailing Address C/O THE CARLYLE GROUP L.P. 1001 PENNSYLVANIA AVENUE, NW WASHINGTON DC 20004
Business Address
Rubenstein David M. (Reporting) CIK: 0001543895 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38753 | Film No.: 25903811

Mailing Address 325 BINNEY STREET CAMBRIDGE MA 02142
Business Address 325 BINNEY STREET CAMBRIDGE MA 02142 6177146500
Moderna, Inc. (Issuer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)